Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

Pharmacology > Basic Principles of Pharmacology > Flashcards

Basic Principles of Pharmacology Flashcards

(72 cards)

Start Studying
1
Q

Drug

A

Any chem that can affect the living processes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Pharmacology

A

Study of drugs & their interactions w/living sys

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Therapeutics

A

The use of drugs to diagnose/prevent/treat disease or to prevent pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Objective of Drug Therapy

A

Provide max benefit w/ min harm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Properties of an Ideal Drug

A

Effectiveness, Safety, & Selectivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Effective

A

Elicits response for which it is given

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Safety

A

Cannot prod harmful effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

True or False (T/F): Not all drugs have the ability to cause harm.

A

F; ALL drugs have the ability to cause injury (especially for those w/increased doses/time infusing)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Selectivity

A

Elicits ONLY response for which it is given

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Additional Properties of an Ideal Drug

A
  1. Reversible action
  2. Predictability
  3. Ease of administration
  4. Freedom from drug interactions
  5. Low cost
  6. Chemical stability
  7. Simple generic name
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What should an ideal drug be able to do, in terms of, ease of administration?

A

Route of administration should be convenient & dose should be low

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are some advantages for a drug that has a convenient route of administration?

A

Can enhance patient adherence & decrease risk for adverse reactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Does chemical instability increase or decrease a drug’s efficacy?

A

Decreases drug efficacy (can decrease if put in improper storage/put in a soln)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Factors that Determine the Intensity of Drug Responses

A

1) Administration (Dose, route, & time)

2) Pharmacokinetics (ADME)

3) Pharmacodynamics

4) Individual Variation (Drug interactions, physiologic variables, pathologic variables, genetic variables)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Steps in Preadministration Assessment

A

1) Collect baseline data (help eval therapeutic &adverse resp)

2) Identify High-Risk Patients via px hx, phys exam, lab data

3) Assess patient capacity for self care

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Example of Preadministration Assessment

A

Measuring patient’s BP prior to administrating antihypertensive agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Predisposing Factors for High-Risk Patients

A

1) Pathophysiology (liver & kidney impairment)

2) Genetic factors

3) Drug allergies

4) Lifespan considerations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Federal Pure Food and Drug Act

A

Set standards for drug quality & purity, in addition to strength

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Food, Drug, & Cosmetic Act

A

All medications must be tested for safety, w/ results reviewed by FDA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Harris-Kefauver Agreements

A

Medications must be proven effective before marketing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Controlled Substance Act

A

Rules made for categorizing medications w/ potential for abuse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

BPCA & PREA

A

Promote research in drug safety and efficacy in children w/ clinical trials

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

FDA Amendments Act

A

Include rigorous oversight of drug safety after approval

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Schedule I Drugs

A
  • High Potential for abuse
  • No currently accepted medical use or treatment in US
  • Lack of accepted safety
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Schedule II Drugs
- High potential for abuse - Currently accepted medical use in the U.S. - Abuse may lead to severe psych/phys dependence
26
Schedule III Drugs
- Potential for abuse less than Schedule I & II drugs - Currently accepted medical use in the U.S. - Abuse may lead to mod/low physical dependence or high psych dependence
27
Schedule IV Drugs
- Lower potential for abuse < Schedule III Drugs - Currently accepted medical use in the US - Abuse may lead to lim phys/psychological dependence relative to schedule III substances
28
Schedule V Drugs
- Low potential for abuse rel to Schedule IV Drugs - Currently accepted medical use in the U.S. - Abuse may lead to limited phys/psych dependence rel to schedule IV drugs - May be dispensed w/out medical reason
29
Random Controlled Trial (RCT)
Most reliable way to objectively assess drug therapies
30
3 Distinguishing Features of RCTs
1) Use of Controls 2) Randomization 3) Blinding
31
What is the purpose of using controls, randomization, and blinding in RCTs?
Minim the influence of personal bias on the results
32
In RCTs some subjects are given the ____ and others the ___.
new drug, standard treatment (placebo)
33
Control
Subject given the standard treatment/placebo
34
What is the purpose of randomization in RCTs?
Prevent allocation bias where subjects in the experimental group are different fro those in the control group
35
Blinded study
Clinical trial in which the patient (single-blind) or patient and investigator (double-blind) are unaware of which treatment the patient receives
36
Stages of New Drug Development
1) Preclinical testing 2) Clinical testing -Phase II -Phase III 3) Phase IV: Postmarketing Surveillance
37
Preclinical Testing Phase
Drugs eval for toxicities, pharmacokinetic prop, & potentially useful bio effects (takes 1-5 yrs) -Tested on animals Sufficient data obtained-> request FDA for permission to test in humans -If granted-> get Investigational New Drug (IND) status
38
Clinical Testing Phase I
Can begin testing in healthy volunteers Tests: Metabolism, pharmacokinetics, & biologic effects
39
Clinical Testing Phase II
Can begin testing in patients (500-5,000 receive it) Tests for therapeutic utility & dosage range
40
Clinical Testing Phase III
Continue testing in patients Tests for safety & efficacy Upon completion-> applies to FDA for conditional approval of New Drug Application
41
Clinical Testing Phase IV: Postmarketing Surveillance
New drug is rel for gen use Permits observation in large pop
42
Limitations in Testing Procedure for New Drug Development
1) Very limit info on med safety in women & children 2) Possibility of undetected adverse effects after going into the market
43
Medication Chemical Name
Describes med using chem nomenclature
44
Example of Med Chemical Name for Acetominophen
N-acetyl-para-aminophenol
45
Medication Generic Name
Name of drug assigned by US Adopted Names Council that is less complex than chemical name
46
Example of Medication Generic Name
Acetaminophen
47
Medication Trade Name
Name under which a drug is marketed under for ease of use and recall
48
Example of Med Trade Name for Acetominophen
Tylenol, Ofirmev, & APAP
49
Pharmacokinetics (ADME)
What the body does to the drug
50
Pharmacokinetics: Absorption
Movement from site of administration to bloodstream
51
What does the rate of absorption determine?
How soon effects will begin
52
What does the amount of absorption determine?
How intense the drug effects will be
53
What does the route of administration affect?
Rate & amnt of absorption
54
What are factors that can affect absorption?
1) Rate of dissolution 2) Surface Area 3) Lipid solubility 4) pH partitioning
55
Oral Med Administration (Capsules, Tablets) Barriers
Epithel lining of GI tract & capillary wall-> absorption is slow & variable
56
Advantages of Oral Med Administration
Easy & convenient to administer Inexpensive & ideal for self-medication Potentially reversible
57
Disadvantages of Oral Med Admin
Variability Inactiv by gastric acid & digestive enzymes (possible N/V) Patient must be conscious & cooperative
58
Sublingual & Buccal Med Administration Barriers & Absorption Pattern
Swallowing before dissoln allows gastric pH to inactiv med Absorption pattern: Quick absorption syst via increased vascular membranes
59
Other Mucous Membrane Meds (Rectal/Vaginal) Barriers & Absorption Pattern
Barriers to absorption: Presc of stool in the rectum in the vagina limits tiss contract Absorption pattern: Easy absorption w/ both local & systemic effects
60
Inhalation Med Barriers & Patterns of Absorption
Barriers to absorption: Inspiratory effort Absorption pattern: Rapid absorption via alveolar capillary networks
61
IM & SQ Med Absorption Barriers & Pattern
Only barrier is capillary wall Rapid absorption w/H2O sol drugs
62
IM & SQ Med Admin Advantages
Permits use of poorly soluble drugs & depot prep
63
IM & SQ Med Admin Disadvantages
Uncomfortable/possib painful Inconvenient w/potential for injury
64
IV Med Absorption
Instantaneous absorption w/no barriers
65
IV Med Admin Advantages
Rapid onset Permits use of large vol & irritant drugs
66
IV Med Admin Disadvantages
Irrev, inconvenient, & expensive Not suited for self admin Risk for fluid overload, infection, & embolism Drugs must be H2O soluble
67
Pharmacokinetics: Distribution
Mvmnt of drugs into cells
68
Factors that Affect Distribution
1) Circulation 2) Cell membrane permeability 3) Plasma-protein binding
69
How does circulation affect distribution?
Conditions that inhibit blood flow delay med distribution
70
How does cell membrane permeability affect distribution?
Meds must be able to pass via tiss & membrane to reach target area
71
How does plasma-protein binding affect distribution?
The ability of a med to bind to a protein can affect how much the med will leave & travel to target tissues
72
Malnourishment & liver pathology can (increase/decrease) albumin stores?
They can decrease albumin stores

Pharmacology (3 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions